Gradually discontinuing sulfasalazine is recommended because of its poorer treatment persistence due to adverse events Gradual discontinuation of methotrexate is conditionally recommended over gradual discontinuation of the bDMARD or tsDMARD for patients taking methotrexate plus a bDMARD or tsDMARD who wish to discontinue a DMARD In the absence of direct evidence, gradually discontinuing methotrexate is preferred because a bDMARD or tsD-MARD is typically added following an inadequate response